Literature DB >> 2988126

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.

W R Ballou, J Rothbard, R A Wirtz, D M Gordon, J S Williams, R W Gore, I Schneider, M R Hollingdale, R L Beaudoin, W L Maloy.   

Abstract

In a study of recombinant proteins that might be useful in developing a vaccine against malaria, synthetic peptides from the circumsporozoite (CS) protein of Plasmodium falciparum were found to be immunogenic for mice and rabbits. Antibody to peptides from the repeating region of the CS protein recognized native CS protein and blocked sporozoite invasion of human hepatoma cells in vitro. Antibodies to peptides from regions I and II had no biologic activity, although antibody to region I recognized processed CS protein by Western blot analysis. These data support the feasibility of developing a vaccine against the sporozoite stage of the malaria parasite by using synthetic peptides of the repeating region of the CS protein conjugated to a carrier protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988126     DOI: 10.1126/science.2988126

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  58 in total

Review 1.  Vaccines for malaria: how close are we?

Authors:  Mahamadou A Thera; Christopher V Plowe
Journal:  Annu Rev Med       Date:  2011-11-10       Impact factor: 13.739

Review 2.  The use of particle concentration fluorescence immunoassay technology for the analysis of rDNA products.

Authors:  B J Del Tito
Journal:  J Ind Microbiol       Date:  1991-09

Review 3.  Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.

Authors:  S J Cryz
Journal:  Experientia       Date:  1991-02-15

Review 4.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

Authors:  L F Fries; D M Gordon; R L Richards; J E Egan; M R Hollingdale; M Gross; C Silverman; C R Alving
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro.

Authors:  P Sharma; A Bharadwaj; V K Bhasin; V N Sailaja; V S Chauhan
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.

Authors:  K D Gibson; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

9.  Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection.

Authors:  H K Webster; A E Brown; C Chuenchitra; B Permpanich; J Pipithkul
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein.

Authors:  Y P Shi; V Udhayakumar; M P Alpers; M M Povoa; A J Oloo; T K Ruebush; A A Lal
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.